Skip to content

ReLine 24017545Recalls & reported problems

Nuvasive, Inc. · RELINE-One Screw, 7.5x45mm 2C EXTTAB · Class 2 · Implant

All models of ReLine (129)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00195377041715), received between Apr 4, 2022 and Apr 4, 2022 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Vertebral Fracture1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 4, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT UNDERWENT AN INITIAL POSTERIOR FIXATION PROCEDURE ON AN UNKNOWN DATE. SUBSEQUENTLY, POST-OPERATIVE IMAGING OBTAINED ON AN UNKNOWN DATE IDENTIFIED FRACTURE OF THE PATIENT'S RIGHT PEDICLE AT L4. THE SURGEON BELIEVES THE FRACTURE OCCURRED DURING INSERTION OF THE SCREW. THERE IS NO INTENT TO REVISE THE IMPLANTED CONSTRUCT AT THIS TIME AND THE PATIENT HAS NO ADVERSE SYMPTOMS. NO FURTHER PATIENT IMPACT WAS REPORTED.

    Patient problems: Vertebral Fracture

    MAUDE report 14004857 ↗

Other APPLIANCE, FIXATION, SPINAL INTERLAMINAL devices

All APPLIANCE, FIXATION, SPINAL INTERLAMINAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page